Apple juice greatly reduces systemic exposure to atenolol.

British Journal of Clinical Pharmacology
Hyewon JeonKyoung Soo Lim

Abstract

Fruit juice reduces the plasma concentrations of several β-adrenoceptor blockers, likely by inhibiting OATP2B1-mediated intestinal absorption. The aim of this study was to investigate the effects of apple juice on the pharmacokinetics of atenolol. Twelve healthy Korean volunteers with genotypes of SLCO2B1 c.1457C> T (*1/*1 (n = 6) and *3/*3 (n = 6)) were enrolled in this study. In a three-phase, one-sequence crossover study, the pharmacokinetics (PK) of atenolol was evaluated after administration of 50 mg atenolol. Subjects received atenolol with either 300 ml water, 1200 ml apple juice or 600 ml apple juice. Apple juice markedly reduced the systemic exposure to atenolol. The geometric mean ratios (95% confidence intervals) of apple juice : water were 0.18 (0.13, 0.25, 1200 ml) and 0.42 (0.30, 0.59, 600 ml) for the AUC(0,t(last)). In this study, the PK parameters of atenolol responded in a dose-dependent manner to apple juice. Apple juice markedly reduced systemic exposure to atenolol. The genetic variation of SLCO2B1 c.1457C>T had a minimal effect on the pharmacokinetics of atenolol when the drug was administered with water or apple juice.

References

Jun 1, 1979·British Journal of Clinical Pharmacology·S H WanR F Maronde
May 17, 1978·European Journal of Clinical Pharmacology·J D FitzgeraldJ McAinsh
Jan 1, 1988·European Journal of Clinical Pharmacology·I BlomqvistP Lundborg
Apr 6, 2002·Reproductive Toxicology·Sonia A Tabacova, Carole A Kimmel
Mar 7, 2003·Clinical Pharmacology and Therapeutics·Jari J LiljaPertti J Neuvonen
May 16, 2003·JAMA : the Journal of the American Medical Association·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Aug 2, 2003·Pharmacogenetics·Deanna L KroetzUNKNOWN Pharmacogenetics of Membrane Transporters Investigators
Mar 6, 2004·Clinical Pharmacology and Therapeutics·Jari J LiljaPertti J Neuvonen
Jan 11, 2005·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Hiroki SatohYasufumi Sawada
May 21, 2005·Clinical Pharmacology and Therapeutics·Ute I SchwarzWilhelm Kirch
Jun 29, 2005·European Journal of Clinical Pharmacology·J J LiljaP J Neuvonen
Nov 25, 2005·British Journal of Clinical Pharmacology·Jari J LiljaPertti J Neuvonen
Jun 15, 2007·Journal of Hypertension·David F BlackburnJames L Blackburn
Feb 6, 2008·Blood·Michael D CaldwellJames K Burmester
May 23, 2009·Inflammatory Bowel Diseases·Marco ZucchelliMauro D'Amato
Oct 16, 2009·European Journal of Clinical Pharmacology·Mutasim A Al-GhazawiSalah M AbuRuz
Mar 2, 2010·Nature Reviews. Drug Discovery·UNKNOWN International Transporter ConsortiumLei Zhang
Jun 22, 2010·Basic & Clinical Pharmacology & Toxicology·Alli Laitinen, Mikko Niemi
Jul 29, 2010·Clinical Pharmacology and Therapeutics·T TapaninenM Niemi
Aug 28, 2010·Pharmacotherapy·Hrishikesh A NavareJulie A Johnson
Oct 27, 2010·Journal of Clinical Pharmacology·E B MougeyJ J Lima
Nov 3, 2010·British Journal of Clinical Pharmacology·David G Bailey
Jan 6, 2011·British Journal of Clinical Pharmacology·Tuija TapaninenMikko Niemi
Jun 22, 2011·Pharmacogenetics and Genomics·Ichiro IeiriYuichi Sugiyama
Aug 10, 2011·Advanced Drug Delivery Reviews·Ikumi Tamai

❮ Previous
Next ❯

Citations

Jun 23, 2015·Journal of Clinical Pharmacology·Guohua AnReginald F Frye
Jan 24, 2014·British Journal of Clinical Pharmacology·Albert FerroJames M Ritter
Jul 23, 2016·Frontiers in Pharmacology·Yun ShanJun Sheng
Jul 8, 2016·Journal of Clinical Pharmacology·Frédérique RodieuxJohannes N van den Anker
Oct 5, 2016·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Nazareth Eliana CeschanHugh David Charles Smyth
Apr 18, 2017·Journal of Pharmaceutical Sciences·Jingjing YuIsabelle Ragueneau-Majlessi
Oct 27, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Ghulam MurtazaUNKNOWN Mariam
Oct 28, 2017·Drugs·Jianyuan DengTai Ning Lam
Jan 10, 2019·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Yuta FunaiKatsuhisa Inoue
May 28, 2019·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Samantha MedwidRommel G Tirona
Dec 25, 2012·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Yoshiyuki ShirasakaIkumi Tamai
Sep 17, 2015·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Jia YinJoanne Wang
Apr 29, 2018·Journal of Food and Drug Analysis·Meng ChenQuan Zhou
May 8, 2020·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Yoshiyuki Shirasaka
Jun 24, 2020·Proceedings of the National Academy of Sciences of the United States of America·Ling ZouPeter J Turnbaugh
Nov 2, 2017·Fluids and Barriers of the CNS·Xiaomei ChenMargareta Hammarlund-Udenaes
Sep 1, 2018·Translational and Clinical Pharmacology·In-Jin Jang
Feb 25, 2020·Cardiovascular Therapeutics·Irina-Iuliana CostacheAna Clara Aprotosoaie
Dec 30, 2020·Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition·Joseph I Boullata
Dec 31, 2020·Foods·Zvonimir PetricDanijela Bursać Kovačević
Dec 20, 2020·Expert Opinion on Drug Metabolism & Toxicology·Baron Bechtold, John Clarke

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.